Teva announced the launch of Dexmethylphenidate HCl Extended-Release Capsules, the generic version of Novartis’ Focalin XR.
Dexmethylphenidate HCl is a CNS stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD). Dexmethylphenidate, the more pharmacologically active d-enantiomer of racemic methylphenidate, is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.
Dexmethylphenidate HCl Extended-Release Capsules are available in 15mg, 30mg, and 40mg strengths in 100-count bottles.
For more information call (888) 838-2872 or visit TevaGenerics.com.
